Amphastar Pharmaceuticals, Inc. Logo

Amphastar Pharmaceuticals, Inc.

Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.

AMPH | US

Overview

Corporate Details

ISIN(s):
US03209R1032 (+3 more)
LEI:
54930055TH0ZLSAQMJ38
Country:
United States of America
Address:
11570 SIXTH STREET, 91730 RANCHO CUCAMONGA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development, manufacturing, and marketing of complex and technically challenging pharmaceutical products. The company's portfolio primarily consists of generic and proprietary injectable, intranasal, and inhalation drugs. It specializes in complex medications, including biologics, interchangeable biosimilars, and proteins, and also manufactures its own active pharmaceutical ingredients (APIs) such as insulin. Amphastar leverages its state-of-the-art, cGMP-compliant facilities to create innovative drug delivery systems and proprietary technological platforms, targeting difficult-to-produce medications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 00:00
Investor Presentation
Q3 2025 Earnings Presentation
English 3.4 MB
2025-09-03 00:00
Investor Presentation
Wells Fargo Healthcare Presentation
English 3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amphastar Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biohaven Ltd. Logo
Clinical-stage biopharma developing drugs for neuroscience, immunology, and oncology.
United States of America
BHVN
BioInfra Co.,Ltd. Logo
Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.
South Korea
199730
BioInfra Life Science Inc. Logo
Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.
South Korea
266470
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel
BLRX
BIOMARIN PHARMACEUTICAL INC Logo
Develops and commercializes therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland
BMX
Biomea Fusion, Inc. Logo
Develops oral small molecules for metabolic diseases like diabetes and for specific cancers.
United States of America
BMEA
BIOMERICA INC Logo
Develops diagnostic tests for GI, inflammatory diseases, and diabetes for lab and at-home use.
United States of America
BMRA
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France
BIM

Talk to a Data Expert

Have a question? We'll get back to you promptly.